Dr. Kenichi Okuda, a Research Associate at Marsico Lung Institute at University of North Carolina at Chapel Hill, discusses his research to identify cell types that contribute CFTR expression and function along the proximal-distal axis of the normal human lung. The presentation describes the methods and results of his experiments as well as their potential impact on the development of precision medicine therapies for cystic fibrosis. This presentation was part of CFRI's Virtual 34th National CF Education Conference on July 31, 2021.
CFRI's 34th National CF Education Conference was sponsored by Vertex Pharmaceuticals, Genentech, Gilead Sciences, Chiesi USA, AbbVie, and Ionis Pharmaceuticals.